BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36717104)

  • 1. Loss-of-function K
    Nam YW; Rahman MA; Yang G; Orfali R; Cui M; Zhang M
    Am J Physiol Cell Physiol; 2023 Mar; 324(3):C658-C664. PubMed ID: 36717104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Channelopathy of small- and intermediate-conductance Ca
    Nam YW; Downey M; Rahman MA; Cui M; Zhang M
    Acta Pharmacol Sin; 2023 Feb; 44(2):259-267. PubMed ID: 35715699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Channelopathy-causing mutations in the S
    Orfali R; Nam YW; Nguyen HM; Rahman MA; Yang G; Cui M; Wulff H; Zhang M
    Cell Calcium; 2022 Mar; 102():102538. PubMed ID: 35030515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminar shear stress upregulates endothelial Ca²⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca²⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
    Takai J; Santu A; Zheng H; Koh SD; Ohta M; Filimban LM; Lemaître V; Teraoka R; Jo H; Miura H
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H484-93. PubMed ID: 23792675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1.
    Gao Y; Chotoo CK; Balut CM; Sun F; Bailey MA; Devor DC
    J Biol Chem; 2008 Apr; 283(14):9049-59. PubMed ID: 18227067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
    Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
    PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.
    Brown BM; Shim H; Christophersen P; Wulff H
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():219-240. PubMed ID: 31337271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tremor dominant Kyoto (Trdk) rats carry a missense mutation in the gene encoding the SK2 subunit of small-conductance Ca
    Kuramoto T; Yokoe M; Kunisawa N; Ohashi K; Miyake T; Higuchi Y; Yoshimi K; Mashimo T; Tanaka M; Kuwamura M; Kaneko S; Shimizu S; Serikawa T; Ohno Y
    Brain Res; 2017 Dec; 1676():38-45. PubMed ID: 28917524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-Selective Positive Modulation of K
    Nam YW; Pala R; El-Sayed NS; Larin-Henriquez D; Amirrad F; Yang G; Rahman MA; Orfali R; Downey M; Parang K; Nauli SM; Zhang M
    ACS Chem Biol; 2022 Aug; 17(8):2344-2354. PubMed ID: 35947779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).
    Christophersen P; Wulff H
    Channels (Austin); 2015; 9(6):336-43. PubMed ID: 26217968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca
    Bauer CK; Schneeberger PE; Kortüm F; Altmüller J; Santos-Simarro F; Baker L; Keller-Ramey J; White SM; Campeau PM; Gripp KW; Kutsche K
    Am J Hum Genet; 2019 Jun; 104(6):1139-1157. PubMed ID: 31155282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
    Oliván-Viguera A; Valero MS; Coleman N; Brown BM; Laría C; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Wulff H; Badorrey R; Köhler R
    Mol Pharmacol; 2015 Feb; 87(2):338-48. PubMed ID: 25468883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium dependence of both lobes of calmodulin is involved in binding to a cytoplasmic domain of SK channels.
    Halling DB; Philpo AE; Aldrich RW
    Elife; 2022 Dec; 11():. PubMed ID: 36583726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between functional inhibition and binding for K(Ca)2 channel blockers.
    Benton DC; Garbarg M; Moss GW
    PLoS One; 2013; 8(9):e73328. PubMed ID: 24039913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial K
    Li JJ; Zhao XY; Wang Y; Xu R; Di XH; Zhang Y; Yang H; Han MZ; Bai RY; Xie L; Pang ZD; Zhang X; Zhang J; Du XJ; Deng XL; Zhang Y; Xie W
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):726-738. PubMed ID: 36951065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.
    Wandall-Frostholm C; Skaarup LM; Sadda V; Nielsen G; Hedegaard ER; Mogensen S; Köhler R; Simonsen U
    PLoS One; 2014; 9(5):e97687. PubMed ID: 24858807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute epileptiform activity induced by gabazine involves proteasomal rather than lysosomal degradation of K
    Müller S; Guli X; Hey J; Einsle A; Pfanz D; Sudmann V; Kirschstein T; Köhling R
    Neurobiol Dis; 2018 Apr; 112():79-84. PubMed ID: 29330041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors (HDACi) increase expression of KCa2.3 (SK3) in primary microvascular endothelial cells.
    Kolski-Andreaco A; Balut CM; Bertuccio CA; Wilson AS; Rivers WM; Liu X; Gandley RE; Straub AC; Butterworth MB; Binion D; Devor DC
    Am J Physiol Cell Physiol; 2022 Mar; 322(3):C338-C353. PubMed ID: 35044858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K
    Abiraman K; Tzingounis AV; Lykotrafitis G
    FASEB J; 2018 Apr; 32(4):1794-1805. PubMed ID: 29180442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db Mice.
    Comerma-Steffensen S; Prat-Duran J; Mogensen S; Fais R; Pinilla E; Simonsen U
    J Sex Med; 2022 May; 19(5):697-710. PubMed ID: 35321830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.